Authors: Yiannoutsos, CT De Luca, A

Citation: Ct. Yiannoutsos et A. De Luca, Designs for clinical trials to test the efficacy of therapeutics in progressive multifocal leukoencephalopathy, J NEUROVIRO, 7(4), 2001, pp. 369-374

Authors: Hewitt, RG Yiannoutsos, CT Higgs, ES

Citation: Rg. Hewitt et al., Paromomycin in cryptosporidiosis - Reply, CLIN INF D, 32(10), 2001, pp. 1517-1517

Authors: Hewitt, RG Yiannoutsos, CT Higgs, ES Carey, JT Geiseler, PJ Soave, R Rosenberg, R Vazquez, GJ Wheat, LJ Fass, RJ Antoninievic, Z Walawander, AL Flanigan, TP Bender, JF

Citation: Rg. Hewitt et al., Paromomycin: No more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection, CLIN INF D, 31(4), 2000, pp. 1084-1092

Authors: Yiannoutsos, CT Major, EO Curfman, B Jensen, PN Gravell, M Hou, J Clifford, DB Hall, CD

Citation: Ct. Yiannoutsos et al., Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy, ANN NEUROL, 45(6), 1999, pp. 816-820

Authors: Price, RW Yiannoutsos, CT Clifford, DB Zaborski, L Tselis, A Sidtis, JJ Cohen, B Hall, CD Erice, A Henry, K

Citation: Rw. Price et al., Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy, AIDS, 13(13), 1999, pp. 1677-1685